Ming Xia, Pengwei Huang, & Ming Tan. (2022). A Pseudovirus Nanoparticle-Based Trivalent Rotavirus Vaccine Candidate Elicits High and Cross P Type Immune Response. MDPI AG.
Chicago Style (17th ed.) CitationMing Xia, Pengwei Huang, and Ming Tan. A Pseudovirus Nanoparticle-Based Trivalent Rotavirus Vaccine Candidate Elicits High and Cross P Type Immune Response. MDPI AG, 2022.
MLA (9th ed.) CitationMing Xia, et al. A Pseudovirus Nanoparticle-Based Trivalent Rotavirus Vaccine Candidate Elicits High and Cross P Type Immune Response. MDPI AG, 2022.
Warning: These citations may not always be 100% accurate.